The veterinary drug methyl 3-(2-quinoxalinylmethylene)carbazate N 1, N 4-dioxide (Carbadox) has been selectively reduced in good yield at either N 1 or N 4 with the reagents sodium dithionite or phosphorus trichloride, respectively. The identity of the products, which are important metabolites, was established by 1H NMR and by an X-ray crystal structure of the N 1-monodeoxygenated product. The further metabolite, bis(desoxy) Carbadox, was prepared by reduction of Carbadox with a slight excess of sodium dithionite/acetic acid. When a large excess of this reagent was used, a new compound, methyl 3-(2-quinoxalinylmethyl)carbazate, was also formed.
兽药 3-(2-
喹喔啉基亚甲基)
咔唑酸甲酯 N 1、N 4-二氧化物(Carbadox)分别在 N 1 或 N 4 处用二
亚硫酸钠或
三氯化磷试剂进行了选择性还原,收率很高。通过 1H NMR 和 N 1-单脱氧产物的 X 射线晶体结构,确定了重要代谢产物的身份。另一种代谢物--双(脱氧)
卡巴多,是用少量过量的二
亚硫酸钠/
乙酸还原
卡巴多制备的。当使用大量过量的这种试剂时,还会生成一种新的化合物,即 3-(2-
喹喔啉基甲基)
咔唑酸甲酯。